Pathogenesis of non-alcoholic fatty liver disease
J. K. Dowman(Queen Elizabeth Hospital), Philip N. Newsome(King's College London)
Cited by 732
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
|Journal of Hepatology|2011|304
Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease
|JAMA|2024|200
A global research priority agenda to advance public health responses to fatty liver disease
|Journal of Hepatology|2023|132
A global action agenda for turning the tide on fatty liver disease
|Hepatology|2023|90